Table of Content

1 Prophylactic Human Vaccine Market Overview
1.1 Prophylactic Human Vaccine Product Scope
1.2 Prophylactic Human Vaccine Segment by Type
1.2.1 Global Prophylactic Human Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.2.4 Others
1.3 Prophylactic Human Vaccine Segment by Application
1.3.1 Global Prophylactic Human Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Prophylactic Human Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Prophylactic Human Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Prophylactic Human Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Prophylactic Human Vaccine Price Trends (2016-2027)

2 Prophylactic Human Vaccine Estimates and Forecasts by Region
2.1 Global Prophylactic Human Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Prophylactic Human Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Prophylactic Human Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Prophylactic Human Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Prophylactic Human Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Prophylactic Human Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Prophylactic Human Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Prophylactic Human Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Prophylactic Human Vaccine Estimates and Projections (2016-2027)
2.4.3 China Prophylactic Human Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Prophylactic Human Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Prophylactic Human Vaccine Estimates and Projections (2016-2027)
2.4.6 India Prophylactic Human Vaccine Estimates and Projections (2016-2027)

3 Global Prophylactic Human Vaccine Competition Landscape by Players
3.1 Global Top Prophylactic Human Vaccine Players by Sales (2016-2021)
3.2 Global Top Prophylactic Human Vaccine Players by Revenue (2016-2021)
3.3 Global Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prophylactic Human Vaccine as of 2020)
3.4 Global Prophylactic Human Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Prophylactic Human Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Prophylactic Human Vaccine Market Size by Type
4.1 Global Prophylactic Human Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Prophylactic Human Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Prophylactic Human Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Prophylactic Human Vaccine Price by Type (2016-2021)
4.2 Global Prophylactic Human Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Prophylactic Human Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Prophylactic Human Vaccine Price Forecast by Type (2022-2027)

5 Global Prophylactic Human Vaccine Market Size by Application
5.1 Global Prophylactic Human Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Prophylactic Human Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Prophylactic Human Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Prophylactic Human Vaccine Price by Application (2016-2021)
5.2 Global Prophylactic Human Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Prophylactic Human Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Prophylactic Human Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Prophylactic Human Vaccine Price Forecast by Application (2022-2027)

6 North America Prophylactic Human Vaccine Market Facts & Figures
6.1 North America Prophylactic Human Vaccine Sales by Company
6.1.1 North America Prophylactic Human Vaccine Sales by Company (2016-2021)
6.1.2 North America Prophylactic Human Vaccine Revenue by Company (2016-2021)
6.2 North America Prophylactic Human Vaccine Sales Breakdown by Type
6.2.1 North America Prophylactic Human Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Prophylactic Human Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Prophylactic Human Vaccine Sales Breakdown by Application
6.3.1 North America Prophylactic Human Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Prophylactic Human Vaccine Sales Breakdown by Application (2022-2027)

7 Europe Prophylactic Human Vaccine Market Facts & Figures
7.1 Europe Prophylactic Human Vaccine Sales by Company
7.1.1 Europe Prophylactic Human Vaccine Sales by Company (2016-2021)
7.1.2 Europe Prophylactic Human Vaccine Revenue by Company (2016-2021)
7.2 Europe Prophylactic Human Vaccine Sales Breakdown by Type
7.2.1 Europe Prophylactic Human Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Prophylactic Human Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Prophylactic Human Vaccine Sales Breakdown by Application
7.3.1 Europe 120 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 120 Sales Breakdown by Application (2022-2027)

8 China Prophylactic Human Vaccine Market Facts & Figures
8.1 China Prophylactic Human Vaccine Sales by Company
8.1.1 China Prophylactic Human Vaccine Sales by Company (2016-2021)
8.1.2 China Prophylactic Human Vaccine Revenue by Company (2016-2021)
8.2 China Prophylactic Human Vaccine Sales Breakdown by Type
8.2.1 China Prophylactic Human Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Prophylactic Human Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Prophylactic Human Vaccine Sales Breakdown by Application
8.3.1 China 143 Sales Breakdown by Application (2016-2021)
8.3.2 China 143 Sales Breakdown by Application (2022-2027)

9 Japan Prophylactic Human Vaccine Market Facts & Figures
9.1 Japan Prophylactic Human Vaccine Sales by Company
9.1.1 Japan Prophylactic Human Vaccine Sales by Company (2016-2021)
9.1.2 Japan Prophylactic Human Vaccine Revenue by Company (2016-2021)
9.2 Japan Prophylactic Human Vaccine Sales Breakdown by Type
9.2.1 Japan Prophylactic Human Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Prophylactic Human Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Prophylactic Human Vaccine Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Prophylactic Human Vaccine Market Facts & Figures
10.1 Southeast Asia Prophylactic Human Vaccine Sales by Company
10.1.1 Southeast Asia Prophylactic Human Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Prophylactic Human Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Prophylactic Human Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Prophylactic Human Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Prophylactic Human Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Prophylactic Human Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Prophylactic Human Vaccine Market Facts & Figures
11.1 India Prophylactic Human Vaccine Sales by Company
11.1.1 India Prophylactic Human Vaccine Sales by Company (2016-2021)
11.1.2 India Prophylactic Human Vaccine Revenue by Company (2016-2021)
11.2 India Prophylactic Human Vaccine Sales Breakdown by Type
11.2.1 India Prophylactic Human Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Prophylactic Human Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Prophylactic Human Vaccine Sales Breakdown by Application
11.3.1 India Prophylactic Human Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Prophylactic Human Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Prophylactic Human Vaccine Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Prophylactic Human Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Biovac
12.2.1 Biovac Corporation Information
12.2.2 Biovac Business Overview
12.2.3 Biovac Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Biovac Prophylactic Human Vaccine Products Offered
12.2.5 Biovac Recent Development
12.3 McKesson Medical
12.3.1 McKesson Medical Corporation Information
12.3.2 McKesson Medical Business Overview
12.3.3 McKesson Medical Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 McKesson Medical Prophylactic Human Vaccine Products Offered
12.3.5 McKesson Medical Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Business Overview
12.4.3 Merck Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck Prophylactic Human Vaccine Products Offered
12.4.5 Merck Recent Development
12.5 Merial
12.5.1 Merial Corporation Information
12.5.2 Merial Business Overview
12.5.3 Merial Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Merial Prophylactic Human Vaccine Products Offered
12.5.5 Merial Recent Development
12.6 Zoetis
12.6.1 Zoetis Corporation Information
12.6.2 Zoetis Business Overview
12.6.3 Zoetis Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Zoetis Prophylactic Human Vaccine Products Offered
12.6.5 Zoetis Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Business Overview
12.7.3 Sanofi Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sanofi Prophylactic Human Vaccine Products Offered
12.7.5 Sanofi Recent Development
...

13 Prophylactic Human Vaccine Manufacturing Cost Analysis
13.1 Prophylactic Human Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Prophylactic Human Vaccine
13.4 Prophylactic Human Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Prophylactic Human Vaccine Distributors List
14.3 Prophylactic Human Vaccine Customers

15 Market Dynamics
15.1 Prophylactic Human Vaccine Market Trends
15.2 Prophylactic Human Vaccine Drivers
15.3 Prophylactic Human Vaccine Market Challenges
15.4 Prophylactic Human Vaccine Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Prophylactic Human Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Prophylactic Human Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Prophylactic Human Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Prophylactic Human Vaccine Sales (K Units) by Region (2016-2021)
Table 5. Global Prophylactic Human Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Prophylactic Human Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Prophylactic Human Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Prophylactic Human Vaccine Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Prophylactic Human Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Prophylactic Human Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Prophylactic Human Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Prophylactic Human Vaccine Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Prophylactic Human Vaccine Sales Share by Company (2016-2021)
Table 14. Global Prophylactic Human Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Prophylactic Human Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Prophylactic Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic Human Vaccine as of 2020)
Table 17. Global Prophylactic Human Vaccine Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Prophylactic Human Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Prophylactic Human Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Prophylactic Human Vaccine Sales (K Units) by Type (2016-2021)
Table 22. Global Prophylactic Human Vaccine Sales Share by Type (2016-2021)
Table 23. Global Prophylactic Human Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Prophylactic Human Vaccine Price (USD/Unit) by Type (2016-2021)
Table 25. Global Prophylactic Human Vaccine Sales Share by Type (2022-2027)
Table 26. Global Prophylactic Human Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Prophylactic Human Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Prophylactic Human Vaccine Price (USD/Unit) by Type (2022-2027)
Table 29. Global Prophylactic Human Vaccine Sales (K Units) by Application (2016-2021)
Table 30. Global Prophylactic Human Vaccine Sales Share by Application (2016-2021)
Table 31. Global Prophylactic Human Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Prophylactic Human Vaccine Price (USD/Unit) by Application (2016-2021)
Table 33. Global Prophylactic Human Vaccine Sales (K Units) by Application (2022-2027)
Table 34. Global Prophylactic Human Vaccine Sales Share by Application (2022-2027)
Table 35. Global Prophylactic Human Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Prophylactic Human Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Prophylactic Human Vaccine Price (USD/Unit) by Application (2022-2027)
Table 38. North America Prophylactic Human Vaccine Sales (K Units) by Company (2016-2021)
Table 39. North America Prophylactic Human Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Prophylactic Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Prophylactic Human Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Prophylactic Human Vaccine Sales by Type (2016-2021) & (K Units)
Table 43. North America Prophylactic Human Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Prophylactic Human Vaccine Sales by Type (2022-2027) & (K Units)
Table 45. North America Prophylactic Human Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Prophylactic Human Vaccine Sales by Application (2016-2021) & (K Units)
Table 47. North America Prophylactic Human Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Prophylactic Human Vaccine Sales by Application (2022-2027) & (K Units)
Table 49. North America Prophylactic Human Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Prophylactic Human Vaccine Sales (K Units) by Company (2016-2021)
Table 51. Europe Prophylactic Human Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Prophylactic Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Prophylactic Human Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Prophylactic Human Vaccine Sales by Type (2016-2021) & (K Units)
Table 55. Europe Prophylactic Human Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Prophylactic Human Vaccine Sales by Type (2022-2027) & (K Units)
Table 57. Europe Prophylactic Human Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Prophylactic Human Vaccine Sales by Application (2016-2021) & (K Units)
Table 59. Europe Prophylactic Human Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Prophylactic Human Vaccine Sales by Application (2022-2027) & (K Units)
Table 61. Europe Prophylactic Human Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Prophylactic Human Vaccine Sales (K Units) by Company (2016-2021)
Table 63. China Prophylactic Human Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Prophylactic Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Prophylactic Human Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Prophylactic Human Vaccine Sales by Type (2016-2021) & (K Units)
Table 67. China Prophylactic Human Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Prophylactic Human Vaccine Sales by Type (2022-2027) & (K Units)
Table 69. China Prophylactic Human Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Prophylactic Human Vaccine Sales by Application (2016-2021) & (K Units)
Table 71. China Prophylactic Human Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Prophylactic Human Vaccine Sales by Application (2022-2027) & (K Units)
Table 73. China Prophylactic Human Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Prophylactic Human Vaccine Sales (K Units) by Company (2016-2021)
Table 75. Japan Prophylactic Human Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Prophylactic Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Prophylactic Human Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Prophylactic Human Vaccine Sales by Type (2016-2021) & (K Units)
Table 79. Japan Prophylactic Human Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Prophylactic Human Vaccine Sales by Type (2022-2027) & (K Units)
Table 81. Japan Prophylactic Human Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Prophylactic Human Vaccine Sales by Application (2016-2021) & (K Units)
Table 83. Japan Prophylactic Human Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Prophylactic Human Vaccine Sales by Application (2022-2027) & (K Units)
Table 85. Japan Prophylactic Human Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Prophylactic Human Vaccine Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Prophylactic Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Prophylactic Human Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Prophylactic Human Vaccine Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Prophylactic Human Vaccine Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Prophylactic Human Vaccine Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Prophylactic Human Vaccine Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Prophylactic Human Vaccine Sales (K Units) by Company (2016-2021)
Table 99. India Prophylactic Human Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Prophylactic Human Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Prophylactic Human Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Prophylactic Human Vaccine Sales by Type (2016-2021) & (K Units)
Table 103. India Prophylactic Human Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Prophylactic Human Vaccine Sales by Type (2022-2027) & (K Units)
Table 105. India Prophylactic Human Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Prophylactic Human Vaccine Sales by Application (2016-2021) & (K Units)
Table 107. India Prophylactic Human Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Prophylactic Human Vaccine Sales by Application (2022-2027) & (K Units)
Table 109. India Prophylactic Human Vaccine Sales Market Share by Application (2022-2027)
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. GSK Prophylactic Human Vaccine Product
Table 114. GSK Recent Development
Table 115. Biovac Corporation Information
Table 116. Biovac Description and Business Overview
Table 117. Biovac Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Biovac Prophylactic Human Vaccine Product
Table 119. Biovac Recent Development
Table 120. McKesson Medical Corporation Information
Table 121. McKesson Medical Description and Business Overview
Table 122. McKesson Medical Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. McKesson Medical Prophylactic Human Vaccine Product
Table 124. McKesson Medical Recent Development
Table 125. Merck Corporation Information
Table 126. Merck Description and Business Overview
Table 127. Merck Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Merck Prophylactic Human Vaccine Product
Table 129. Merck Recent Development
Table 130. Merial Corporation Information
Table 131. Merial Description and Business Overview
Table 132. Merial Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Merial Prophylactic Human Vaccine Product
Table 134. Merial Recent Development
Table 135. Zoetis Corporation Information
Table 136. Zoetis Description and Business Overview
Table 137. Zoetis Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Zoetis Prophylactic Human Vaccine Product
Table 139. Zoetis Recent Development
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Business Overview
Table 142. Sanofi Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Sanofi Prophylactic Human Vaccine Product
Table 144. Sanofi Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Prophylactic Human Vaccine Distributors List
Table 148. Prophylactic Human Vaccine Customers List
Table 149. Prophylactic Human Vaccine Market Trends
Table 150. Prophylactic Human Vaccine Market Drivers
Table 151. Prophylactic Human Vaccine Market Challenges
Table 152. Prophylactic Human Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Prophylactic Human Vaccine Product Picture
Figure 2. Global Prophylactic Human Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Attenuated Vaccine Product Picture
Figure 5. Others Product Picture
Figure 6. Global Prophylactic Human Vaccine Sales Market Share by Application in 2021 & 2027
Figure 7. Hospital Examples
Figure 8. Scientific Research Examples
Figure 9. Others Examples
Figure 10. Global Prophylactic Human Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Prophylactic Human Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Prophylactic Human Vaccine Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Prophylactic Human Vaccine Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Prophylactic Human Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Prophylactic Human Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Prophylactic Human Vaccine Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Prophylactic Human Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Prophylactic Human Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Prophylactic Human Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Prophylactic Human Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Prophylactic Human Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Prophylactic Human Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Prophylactic Human Vaccine Players Market Share by Revenue in Prophylactic Human Vaccine: 2016 & 2020
Figure 29. Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Prophylactic Human Vaccine Revenue Share by Type (2016-2021)
Figure 31. Global Prophylactic Human Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Prophylactic Human Vaccine Revenue Share by Application (2016-2021)
Figure 33. Global Prophylactic Human Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Prophylactic Human Vaccine Sales Market Share by Type in 2020
Figure 35. North America Prophylactic Human Vaccine Sales Market Share by Application in 2020
Figure 36. Europe Prophylactic Human Vaccine Sales Market Share by Type in 2020
Figure 37. Europe Prophylactic Human Vaccine Sales Market Share by Application in 2020
Figure 38. China Prophylactic Human Vaccine Sales Market Share by Type in 2020
Figure 39. China Prophylactic Human Vaccine Sales Market Share by Application in 2020
Figure 40. Japan Prophylactic Human Vaccine Sales Market Share by Type in 2020
Figure 41. Japan Prophylactic Human Vaccine Sales Market Share by Application in 2020
Figure 42. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Type in 2020
Figure 43. Southeast Asia Prophylactic Human Vaccine Sales Market Share by Application in 2020
Figure 44. India Prophylactic Human Vaccine Sales Market Share by Type in 2020
Figure 45. India Prophylactic Human Vaccine Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Prophylactic Human Vaccine
Figure 48. Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure 49. Prophylactic Human Vaccine Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed